Ark Biosciences (爱科百发生物医药是) is a company that specializes in antiviral and respiratory drug development. It aims to provide treatments for a chronic obstructive pulmonary disease (COPD), respiratory syncytial virus (RSV), idiopathic pulmonary fibrosis (IPF) as well as hepatitis B virus (HBV).
|Employees (est.) (Jun 2021)||4||(-20%)|
Ark Biosciences total Funding
Ark Biosciences latest funding size
Time since last funding
|3 years ago|
Ark Biosciences investors
|Qiming Venture Partners, Oriza Ventures, BioVenture|
When was Ark Biosciences founded?
Ark Biosciences was founded in 2014.
Who are Ark Biosciences key executives?
Ark Biosciences's key executives are Haiqing Yuan and Jim Wu.
How many employees does Ark Biosciences have?
Ark Biosciences has 4 employees.
Who are Ark Biosciences competitors?
Competitors of Ark Biosciences include Strides Pharma, LFB and Cadila Pharmaceuticals.
Where are Ark Biosciences offices?
Ark Biosciences has an office in.
How many offices does Ark Biosciences have?
Ark Biosciences has 1 office.
Receive alerts for 300+ data fields across thousands of companies